Potential treatment of cerebral global ischemia with Oct-4+ umbilical cord matrix cells.
about
Faster recovery of cerebral perfusion in SOD1-overexpressed rats after cardiac arrest and resuscitationModulation of inflammatory responses after global ischemia by transplanted umbilical cord matrix stem cellsImmunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes.Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissuesTherapeutic effects of amniotic fluid-derived mesenchymal stromal cells on lung injury in rats with emphysema.Differentiation of human umbilical cord matrix-derived mesenchymal stem cells into germ-like cellsCell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells.Gene expression modifications in Wharton's Jelly mesenchymal stem cells promoted by prolonged in vitro culturingEffect of human umbilical cord mesenchymal stem cells transplantation on nerve fibers of a rat model of endometriosisIsoflurane does not cause neuroapoptosis but reduces astroglial processes in young adult miceWharton's jelly-derived cells are a primitive stromal cell population.Neuroprotective properties of marrow-isolated adult multilineage-inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers.Edaravone, a free radical scavenger, mitigates both gray and white matter damages after global cerebral ischemia in rats.Stem cells decreased neuronal cell death after hypoxic stress in primary fetal rat neurons in vitro.Role of IGF1R(+) MSCs in modulating neuroplasticity via CXCR4 cross-interaction.Umbilical cord mesenchymal stem cells labeled with multimodal iron oxide nanoparticles with fluorescent and magnetic properties: application for in vivo cell tracking.Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells.The effects of human Wharton's jelly cell transplantation on the intervertebral disc in a canine disc degeneration model.Wharton's jelly mesenchymal stem cells differentiate into retinal progenitor cells.Combination of stem cell mobilized by granulocyte-colony stimulating factor and human umbilical cord matrix stem cell: therapy of traumatic brain injury in rats.BDNF expression is up-regulated by progesterone in human umbilical cord mesenchymal stem cells.In vivo magnetic resonance imaging tracking of SPIO-labeled human umbilical cord mesenchymal stem cells.Cryopreservation effects on Wharton's Jelly Stem Cells proteome.
P2860
Q33450198-7D2BA0E8-95E2-4D62-8F94-82D6EAAB9F35Q33574998-31BB0A5D-379F-4EFD-B186-BB204A1ABB95Q34224955-F10EF7F9-D1F7-4D7D-87BA-91829D17FA0FQ34333323-B7BA37FC-52E1-4B10-B889-EBE19D80DE46Q34363534-2C1F0FF4-8996-40E4-B08D-43C0623E717BQ34474179-020CC6ED-9B66-4C29-9124-734007DB8F96Q34595662-BFC35722-C217-4DDA-BC57-0BDA7F02F23AQ34673909-B4FFE56E-52A0-4D32-A03F-8E12091CB20CQ34992991-50D74128-AFFB-4276-84E0-9FA48BB43314Q35539033-92D62C99-48F1-4861-9A03-5A4D38514DFBQ35658266-2E4519DE-C9EF-4DE5-90C8-B57E3394C6A9Q35849157-869575D7-DC1F-47DC-95AB-CC7D7C101C9AQ35892125-F944F5A3-5ADC-495D-870D-5F326609DBEFQ36072706-99C690E2-03DC-46C5-8F89-3483828E95F1Q36072710-0DCB4C24-2B86-457E-9AB9-8DFD34ED401AQ37227786-9E13D056-FE06-4F82-B358-6F196F1FB336Q37477701-6224F474-D286-4563-BEC4-F5134F7872DBQ39613781-B8AC290B-B636-41E5-97C0-CBD119C2D8A9Q42173034-5D317F9A-84E4-488F-841F-C0D5CAE3E6FAQ42180869-C1C27360-35E8-48D1-815C-D7DF32AB9D66Q43236660-28B6D32B-A313-4F3A-AFD2-10F7812A8D86Q48476727-74586F6A-6718-460D-AE8F-77E6710876C1Q50266845-9AC400E3-B56C-4C8B-A374-A92E23601EA8Q53600709-F657C943-CC1B-46EF-9918-CF89FE38DC2D
P2860
Potential treatment of cerebral global ischemia with Oct-4+ umbilical cord matrix cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Potential treatment of cerebral global ischemia with Oct-4+ umbilical cord matrix cells.
@en
Potential treatment of cerebral global ischemia with Oct-4+ umbilical cord matrix cells.
@nl
type
label
Potential treatment of cerebral global ischemia with Oct-4+ umbilical cord matrix cells.
@en
Potential treatment of cerebral global ischemia with Oct-4+ umbilical cord matrix cells.
@nl
prefLabel
Potential treatment of cerebral global ischemia with Oct-4+ umbilical cord matrix cells.
@en
Potential treatment of cerebral global ischemia with Oct-4+ umbilical cord matrix cells.
@nl
P2093
P2860
P1433
P1476
Potential treatment of cerebral global ischemia with Oct-4+ umbilical cord matrix cells.
@en
P2093
Claudia J Bode
Kathy Mitchell
Renee Dallasen
Sachiko Jomura
P2860
P304
P356
10.1634/STEMCELLS.2006-0055
P577
2006-09-07T00:00:00Z